The FDA inspection is an industry expectation. The 483 is the outcome we hope not to receive when an inspection is complete. When they are issued, 483s share key indicators of the health of our systems, processes and organizations. This webinar focuses on the FDA 483 data from 2019. We will examine Pharmaceutical, Biologic and Medical Device 483 data by industry. The data will share information on findings and how that may inform our efforts moving forward.